Evidence map›Paper›PMID 36311589›Full record

ArticleFrontiers in public health2022

The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai "Peritoneal Dialysis First Policy".

Pornpen Sangthawan, Pinkaew Klyprayong, Sarayut L Geater, Pimwara Tanvejsilp, Sirirat Anutrakulchai, Sarinya Boongird, Pongsathorn Gojaseni, Charan Kuhiran, Pichet Lorvinitnun, Kajohnsak Noppakun and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The catastrophic costs of chronic kidney disease.Nature reviews. Nephrology · 2025
    Article
  9. Article
  10. Article
  11. Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review.International journal of nephrology and renovascular disease · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 2 countries.

Pornpen SangthawanDepartment of Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Pinkaew KlyprayongDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Sarayut L GeaterDepartment of Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Pimwara TanvejsilpDepartment of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.
Sirirat AnutrakulchaiDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Sarinya BoongirdDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pongsathorn GojaseniDepartment of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, Thailand.
Charan KuhiranDepartment of Medicine, Somdej Pranangchao Sirikit Hospital, Chonburi, Thailand.
Pichet LorvinitnunDepartment of Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.
Kajohnsak NoppakunDepartment of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Watanyu ParapiboonDepartment of Medicine, Maharat Nakhonratchasima Hospital, Nakhon Ratchasima, Thailand.
Supinda SirilakDepartment of Internal Medicine, Naresuan University Hospital, Naresuan University, Phitsanulok, Thailand.
Pluemjit TankeeDepartment of Medicine, Vachiraphuket Hospital, Phuket, Thailand.
Puntapong TaruangsriDepartment of Internal Medicine, Nakornping Hospital, Chiang Mai, Thailand.
Pasuree SangsupawanichDepartment of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Piyamitr SritaraDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Nathorn ChaiyakunaprukDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, United States.
Chagriya KitiyakaraDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Mahidol University · THPrince of Songkla University · THBhumibol Adulyadej Hospital · THChiang Mai University · THKhon Kaen University · THMaharat Nakhon Ratchasima Hospital · THNakornping Hospital · THNaresuan University Hospital · THSappasithiprasong Hospital · THUniversity of Utah · USVachira Phuket Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Universal health coverage can decrease the magnitude of the individual patient's financial burden of chronic kidney disease (CKD), but the residual financial hardship from the patients' perspective has not been well-studied in low and middle-income countries (LMICs). This study aimed to evaluate the residual financial burden in patients with CKD stage 3 to dialysis in the "PD First Policy" under Universal Coverage Scheme (UCS) in Thailand. Methods: This multicenter nationwide cross-sectional study in Thailand enrolled 1,224 patients with pre-dialysis CKD, hemodialysis (HD), and peritoneal dialysis (PD) covered by UCS and other health schemes for employees and civil servants. We interviewed patients to estimate the proportion with catastrophic health expenditure (CHE) and medical impoverishment. The risk factors associated with CHE were analyzed by multivariable logistic regression. Results: Under UCS, the total out-of-pocket expenditure in HD was over two times higher than PD and nearly six times higher than CKD stages 3-4. HD suffered significantly more CHE and medical impoverishment than PD and pre-dialysis CKD [CHE: 8.5, 9.3, 19.5, 50.0% ( Conclusions: Despite universal coverage, the residual financial burden remained high in patients with kidney failure. CHE was considerably lower in PD than HD, although the rates remained alarmingly high in the poor. The "PD First' program" could serve as a model for other LMICs. However, strategies to minimize financial distress should be further developed, especially for the poor.

Indexed as

Peritoneal DialysisRenal Insufficiency, ChronicCross-Sectional StudiesHumansPolicyThailandUniversal Health InsuranceAsiacatastrophic health expenditureeconomicimpoverishmentkidney failureuniversal health insurance

Identifiers

PMID36311589
PMCPMC9606783
OpenAlexW4304845333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.